Gene search

Sequence information

Select Gene Cds Cds_length GC_content Pep Pep_length
Vifa3g02427 ATGAAGTTGTTAGAGAAGATGATGTCAATTACAGATCCAATTACAGACTTGGTGCTCTCAAGTGTCAAGGCTTTGTTCCCGCCACCATTCCGAGCTGTGTTGGGTCGTTTTTCGTTTTTCAATGTGGGCCACAGAGGTACAGCTTCGTCCGGACCTCCCATTGATTCCGACCGCATCCATAGCTATAAATATGATGTGTTTATTAGTTTCAGTGGTGCTGACACCCGCAACACTTTTGTTGATCATCTTTATGCTCATTTAACTAGAAAGGGTATTTTTGTCTTCAAGGATGATATAAGGCTACAGAACGGAGAGTCCCTTTCGCCACAACTTATAGATGCAATTGCAAACTCACGAGTTTCTATTGTTGTCTTTTCTCCAAATTATGCCGAGTCAACATGGTGTTTGGAAGAAATGGCTACTATTGCTGAATGTCGTAAATATTTGAAACAAACTGTGTTCCCTGTTTTTTATGATATCAATCCATCTCATGTACGAAAACAGAATGGGGTGTACCAGAATGCCTTTGTTTTACACATGGAGAATTTTATAAATGATCGGAATAAGGTTGTGAGATGGAAGAGAGCTATGGTCGATTTAGCTGACATAGTTGGTTGGGATGTTAGGAACAAGCCAGAGTTTCGAGCAATTAAAGATATTGTTCAGGAAGTGATAAAAAAATTGGGTCATAAATTCTCAGGGTTTACTGATGACCTTATTGGGATACAACCTCGAGTAGAAGCATTACAAAGTCTTTTGAAATTAAGCTCAAAGGATGATGAATTCCGCGTTGTAGGTATTTGGGGGATGGCTGGAATCGGAAAGACAACTCTCGCTTCTGTCTTGTATGATAGAATCTCCTATCAGTTTGATGCATGTTGTTTTATTGAGAATGTAAGCAAAATTTATAAAGATGGTGGTGCTACTGCTGTACAGATACAAATCCTTCGGCAAACCATAGATGAAATAAATCTAGAGACATACAGCCCTTCTGAAATATCTGGAATTATAAGTAATCGACTATGCAGAAGAAAGATTCTTTTAGTTCTTGACAATGCTGATCTATTAGAGCAACTGGAAGATTTGGCTATAAATCCCGAGTTGCTTGGGACAGGAAGCAGAATGATCATTACAACTAGGGATATGCATATTCTAAGGGTGTTTACAGCACAGTTATCAGTCTCTCACGATACACGCCTGTCGTATGGTGTGTATGAGGTTCCACTGTTAAATAACAAAGATGCTTGCGAATTATTTTACAGAAAAGCTTTTAAAGGTAAGACTCCCACTAGCGAATGTGTGGAGCTGACTTCAGAGGTGCTAAACTATACTCAAGGTCTGCCAATAGCAGTTCGAGTTGTGGGTTCTTTCTTATGTACTCGAAATGCTAGCCAATGGAAAGATGCCTTGGATAGATTGAGGAGTAATCCAGACAAAAAAATTATGGATGTGCTTCTGGTAGGTTTTGAGGGATTACATTACGAGGAAAAAGAAATATTTCTGCATATTTCTTGTTTCTTTAAGAGAGAGAAGGAAGATTATGTGAAGCGAATTTTAGATGCTTGTGATTTGCACCCTGTCATTGGAATTCAAAGTTTAGTAGAGAGGTCATTCATAACTATTAGAAATCAGGAAATTCATATGCATGATATGTTGCAAGAATTGGGGAAGAAAATTGTTCGACAACAGTTTCCTGACGAACCAGGATCGCGGAGTAGATTGTGGCTTTATGAGGATTTCTACAATGTCATGATGACAGAAACGGGAACAAACAACGTTAAAGCCATAATTCTAGATCAAAAGGGGCATAATTCTGAATATCCTCTGTTGAGGGCTGAAGGATTATCAATAATGAGGGGACTTAAAATTCTTATATTACATCATAAGAAATTTTCAGGAAGTCTGGATTTTCTTTCTAACAGCTTGCAGTATCTTCTGTGGTACGGTTACCCTTTTGCTTCTTTGCCATTAAATTTTGAGCCGTTTCGACTTGTCGAATTGAATATGCCTTGTAGTCTCATCCAACGACTATGGGACGGTCACAAGGATCTCCCTTGTTTGAAAAGGGTGGATCTGAGCAACTCTAAATGTCTTGTGGAGACACCAAATTTTGCAGGAAGCCGGAGCCTTGAGCGGCTAGATCTTACAGGATGCATAAGCCTATCGTATGTCCATCCATCCATTGGACTTCTGGAAAAACTTGTTTTCTTGAGTTTGGAAGGTTGCAGCAGTCTGGCCAGGCTCGTTCTTGATGGTGACACTGCATTGTACTTACATTCTCTCAAAGTTTTGCACCTGTCTGGCTGCACAAAACTTGAAACCACGCCCGATTTTACCGAGATGTCAAATCTTGAGTATCTTGATATTGATCAAAGTGTGAGTTTATTGACGATTGATCAATCGATTGGGGATCTTACACATCTTAAGTTCTTGAGTTTAAGAGACTGCACGAATCTTGTCAGTATGCCCAAAAGCATTAGTTCTATAATACCATCTCTTGTGACTTTAGACTTATGTGGCTGCTTAAAATTAAAGAGTCTACCCTTGGAGAAAAACATATCACTGCCTGGAGAAATTATTGACCACTTTGATGAGGTTATGGTATCTTTGATTTTTTTGGACCTAAGCTTTTGCAGTCTTAGTACAGTCCCTGATGCTATTGCAGAGTTAAGGCATTTAGAAAGGCTAAACCTTGAAGGAAATAACTTCAAATCACTACCATCTTCAATGGGGAGGCTTTCCAGACTAGCACATTTAAATTTGGCGCATTGCAGCATGCTTCAATCTTTGCCTGAGCTCGAATTGTGTGCTACTTCTTCATCTGGGGGAAACTATTTTAAATTGTTGTCTGGATCTCATAATCATAGGTCGGGATTATATATTTTCAATTCTCCCCTCTTGGAGAACCCGGAAGGAAGTGTTAACTTGGCACTTTCGTGGCTGATAAAATTAGTTGAGAAACCTTGTCACTTCCGATGTGGTCTAGACATTGTTGTTCCTGGATACCCATTTCCGCGGTGGTTTTCTCATCAATTTAAGGGAATTTCAACAGTTAGGATAGCAGGCTATGCGGATGTGTTTGACAATTGGATTGGCTTTGCTTTTGGTGTGGCATTTGTGGAAAATTGTCGCCCAGCAACATCTGGTTCTTCTCATTGTTCATTATCGTCACAGCTTCCATATCCTCTTTATCTCTCTTTTGAAAGTGAACAAACGGAAGAAACCTTTGATATGCCGCTTCGGTTAGACCTGAACAAGGTTGATGGCTCAAATACAGAACACATCTGGCTAATCTATATCTCTAGGCCACACTGCCATTTTGTAACAACAGGAGCACGTATCACTTTTAAAGCTCACCCAGACGTGGAGTTGAAAACATGGGGATTACGCATGGTATTCAAGCACGATATCTCTAATTCATTCGAGTTGGGGACAAATGAGATTCATCAACAAGGAGGTTATCTTCACTTGGATTATGTATATGAAAGTAGCAGCAGAAGGAGTCCCGATGTCCAGCTTCCTTATAACTGGAATGTTACCAAGGAAGAGCGTGTTACCGAGGAAGAGTCTAAAATGCAGCTTCGCTATAACTGGCATGTTACCGAGGAAGATGAAAACGAGAATAGGGAAGTGAATGTGAAACAAAATCATCTCTTGAATATGGGCCTTTAA 3672 0.3979 MKLLEKMMSITDPITDLVLSSVKALFPPPFRAVLGRFSFFNVGHRGTASSGPPIDSDRIHSYKYDVFISFSGADTRNTFVDHLYAHLTRKGIFVFKDDIRLQNGESLSPQLIDAIANSRVSIVVFSPNYAESTWCLEEMATIAECRKYLKQTVFPVFYDINPSHVRKQNGVYQNAFVLHMENFINDRNKVVRWKRAMVDLADIVGWDVRNKPEFRAIKDIVQEVIKKLGHKFSGFTDDLIGIQPRVEALQSLLKLSSKDDEFRVVGIWGMAGIGKTTLASVLYDRISYQFDACCFIENVSKIYKDGGATAVQIQILRQTIDEINLETYSPSEISGIISNRLCRRKILLVLDNADLLEQLEDLAINPELLGTGSRMIITTRDMHILRVFTAQLSVSHDTRLSYGVYEVPLLNNKDACELFYRKAFKGKTPTSECVELTSEVLNYTQGLPIAVRVVGSFLCTRNASQWKDALDRLRSNPDKKIMDVLLVGFEGLHYEEKEIFLHISCFFKREKEDYVKRILDACDLHPVIGIQSLVERSFITIRNQEIHMHDMLQELGKKIVRQQFPDEPGSRSRLWLYEDFYNVMMTETGTNNVKAIILDQKGHNSEYPLLRAEGLSIMRGLKILILHHKKFSGSLDFLSNSLQYLLWYGYPFASLPLNFEPFRLVELNMPCSLIQRLWDGHKDLPCLKRVDLSNSKCLVETPNFAGSRSLERLDLTGCISLSYVHPSIGLLEKLVFLSLEGCSSLARLVLDGDTALYLHSLKVLHLSGCTKLETTPDFTEMSNLEYLDIDQSVSLLTIDQSIGDLTHLKFLSLRDCTNLVSMPKSISSIIPSLVTLDLCGCLKLKSLPLEKNISLPGEIIDHFDEVMVSLIFLDLSFCSLSTVPDAIAELRHLERLNLEGNNFKSLPSSMGRLSRLAHLNLAHCSMLQSLPELELCATSSSGGNYFKLLSGSHNHRSGLYIFNSPLLENPEGSVNLALSWLIKLVEKPCHFRCGLDIVVPGYPFPRWFSHQFKGISTVRIAGYADVFDNWIGFAFGVAFVENCRPATSGSSHCSLSSQLPYPLYLSFESEQTEETFDMPLRLDLNKVDGSNTEHIWLIYISRPHCHFVTTGARITFKAHPDVELKTWGLRMVFKHDISNSFELGTNEIHQQGGYLHLDYVYESSSRRSPDVQLPYNWNVTKEERVTEEESKMQLRYNWHVTEEDENENREVNVKQNHLLNMGL 1223
       

Annotation information

Select Seq ID Length Analysis Description Start End IPR GO
Vifa3g02427 1223 Gene3D Ribonuclease Inhibitor 854 976 IPR032675 -
Vifa3g02427 1223 Gene3D Ribonuclease Inhibitor 755 853 IPR032675 -
Vifa3g02427 1223 SMART till_3 63 203 IPR000157 GO:0007165
Vifa3g02427 1223 SUPERFAMILY P-loop containing nucleoside triphosphate hydrolases 236 503 IPR027417 -
Vifa3g02427 1223 SUPERFAMILY Toll/Interleukin receptor TIR domain 56 206 IPR035897 -
Vifa3g02427 1223 PANTHER LEUCINE-RICH REPEAT-CONTAINING PROTEIN 64 748 IPR044974 GO:0006952
Vifa3g02427 1223 Gene3D - 235 394 IPR027417 -
Vifa3g02427 1223 Gene3D Ribonuclease Inhibitor 572 754 IPR032675 -
Vifa3g02427 1223 PRINTS Disease resistance protein signature 444 458 - -
Vifa3g02427 1223 PRINTS Disease resistance protein signature 756 772 - -
Vifa3g02427 1223 PRINTS Disease resistance protein signature 264 279 - -
Vifa3g02427 1223 PRINTS Disease resistance protein signature 340 354 - -
Vifa3g02427 1223 Pfam NB-ARC domain 254 478 IPR002182 GO:0043531
Vifa3g02427 1223 SUPERFAMILY L domain-like 548 941 - -
Vifa3g02427 1223 Pfam TIR domain 63 232 IPR000157 GO:0007165
Vifa3g02427 1223 ProSiteProfiles Leucine-rich repeat profile. 892 913 IPR001611 GO:0005515
Vifa3g02427 1223 Gene3D - 409 493 IPR042197 -
Vifa3g02427 1223 Pfam Leucine Rich Repeat 664 680 IPR011713 -
Vifa3g02427 1223 FunFam Disease resistance protein (TIR-NBS-LRR class) 60 230 - -
Vifa3g02427 1223 SMART LRR_typ_2 867 889 IPR003591 -
Vifa3g02427 1223 SMART LRR_typ_2 890 913 IPR003591 -
Vifa3g02427 1223 Gene3D - 58 233 IPR035897 -
Vifa3g02427 1223 ProSiteProfiles TIR domain profile. 62 228 IPR000157 GO:0007165
       

Duplication type information

Select Gene Chromosome Start End Duplicated_type
Vifa3g02427 Vifa-Chr3 614377987 614383487 Dispersed/Transposed
       

Functional genes information

Select Gene Gene_start Gene_end Function Ath_gene Identity(%) E-value Score
Vifa3g02427 732 932 WRKY Transcription Factor Family AT4G12020 31.731 5.72e-12 68.9
       

Pathway information

Select Query KO Definition Second KO KEGG Genes ID GHOSTX Score
Vifa3g02427 - - psat:127091204 2078.91